Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes
Lauren E. Cain(Harvard University), Miguel A. Hernán(Harvard University), Vasilis Paparizos(Harvard University), Roberto Muga, Rafael Rubio(Research Institute Hospital 12 de Octubre), Jonathan A C Sterne(University of Bristol), Heiner C. Bucher(University of Basel), Amy C. Justice(Yale University), Ashley Olson(MRC Human Nutrition Research), Anna Esteve(Harvard University), Dominique Costagliola(Inserm), Inmaculada Jarrín(Instituto de Salud Carlos III), Ellen C. Caniglia(Botswana Harvard AIDS Institute Partnership), Sophie José(NHS England), Giota Touloumi(National and Kapodistrian University of Athens), Jan Fehr(University Hospital of Zurich), James M. Robins(Harvard University), Caroline Sabin(Primary Health Care), Laurence Meyer(Université Paris-Sud), Janet P. Tate, Santiago Pérez‐Hoyos(Vall d'Hebron Hospital Universitari), Ard van Sighem(Stichting HIV Monitoring), Andrew Phillips(University College London), Marie-Anne Vandenhende(Université de Bordeaux), Sophie Abgrall(Inserm), François Dabis(Université de Bordeaux), Jordi Casabona(Universitat Autònoma de Barcelona), Roger Logan(Harvard University), Rémonie Seng(Université Paris-Sud), Peter Reiss(Amsterdam Institute for Global Health and Development)
Cited by 3
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
|International Journal of Obesity|2012|2.1k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k